SUCCESS: Series of Unique Creative Continuing Education Self Studies

You are not logged in. (Login)


CME COURSES | BLOOD MANAGEMENT

Overuse of Blood Transfusions and Growing Evidence in Favor of Patient-Centered Blood Management (Release Date: 05/01/2013)
Red blood cell use in the United States expanded rapidly between 1994 and 2008, suggesting a high proportion of unnecessary transfusions. This program describes the growth of, and drivers for, Patient-Centered Blood Management which promotes the transfusion of fewer blood products for more appropriate, evidence-based indications, promising better patient outcomes and more efficient use of healthcare resources.

Red Cell Transfusion Triggers (Release Date: 05/01/2013)
Red blood cell transfusions are lifesaving when used appropriately. Basic science and randomized, controlled clinical trials now support the use of conservative transfusion practices. Hospital Transfusion Committees should establish consensus transfusion guidelines using evidence-based triggers and educate their physicians regarding implementation of these practices.

The Effect of Red Cell Storage Duration in Clinical Outcomes ( Release Date: 06/05/2013)
Red cells undergo a series of morphological and biochemical changes over time, termed the storage lesion. Transfusion of older red cells has been associated with poorer clinical outcomes in animal and retrospective clinical studies, suggesting a need to change clinical practice. These studies are confounded by methodological weaknesses and confirmation will require large prospective randomized, controlled trials which are currently underway. Pilot randomized feasibility studies do not yet support an urgent need to change current practice.

Evidence-Based Platelet Transfusion Practice (release date June 20, 2013) Platelets are transfused to treat active bleeding or to prevent bleeding in patients about to undergo invasive procedures or who have counts below pre-specified thresholds. Evidence-based guidelines establishing appropriate thresholds and appropriate dosing for a variety of clinical conditions and planned procedures facilitate better transfusion practice. Opportunities exist to develop strong guidelines, educate physicians regarding their evidence-base and prevent unnecessary transfusion.

Plasma Transfusions: Evidence-Based Guidelines (release date: July 11, 2013) The use of plasma has significantly increased over the past several decades. It is generally accepted that a significant proportion of plasma transfusions are inappropriate. Learn what evidence based guidelines have to say about common clinical uses of plasma for bleeding or prevention of bleeding.

Preoperative Anemia and Anemia Management (release date: November 13, 2013) This course will review the significance and prevalence of preoperative anemia The elements of a preoperative anemia management program will be covered, and practical advice on testing, treatment, program logistics, and reimbursement will be provided.

Perioperative Blood Recovery & Acute Normovolemic Hemodilution (release date: August 27, 2014) This course addresses two approaches to providing autologous blood for patients undergoing surgery: perioperative salvage and acute normovolemic hemodilution (ANH). The technical and clinical aspects will be discussed as well as the indications, advantages, disadvantages, and possible complications. The program concludes with a discussion of how salvage and ANH might contribute to a complete transfusion program.

Massive Transfusion Protocols: The Rationale for Ratios and the Impact on Patients (release date: November 13 2014) In this program, the rationale for developing massive transfusion protocols will be reviewed. The evidence in the literature supporting and refuting the use of high ratios of plasma to red blood cells will also be discussed. Lastly, new ideas and products that should be considered for use in a massive transfusion protocol will be described.

Type O Negative Red Blood Cell Utilization: Preserving this Rare and Lifesaving Resource (release date November 3 2015): Type O negative blood – every hospital wants a supply on its shelves. But with a prevalence of only seven percent within the population, this valuable resource must be managed with care. Dr. Mair will discuss ways to best utilize lifesaving type O negative red blood cells.